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Abstract 
Significant efforts have been made in recent years to bridge the gap between research and 
practice. As empirically-supported treatments (using evidence to inform practice) become the 
preferred choice of treatment in clinical settings, additional research is necessary to refine 
aspects of the development, implementation and interpretation of such interventions. Monitoring 
treatment fidelity, specifically, adherence to the treatment protocol, within these interventions 
will provide researchers with additional information about the treatment’s utility and 
effectiveness. The present study describes the development and psychometric properties of the 
Therapist Adherence Checklist, a measure used to assess treatment adherence in Multi-Family 
Psychoeducational Psychotherapy (MF-PEP) for Autism Spectrum Disorders (ASD), an 
intervention designed for children aged 8-12 with an ASD and their families. Two groups of MF-
PEP each consisting of nine weekly sessions, were evaluated. Adherence measures specific to 
each session’s topics and goals were developed. Three trained research assistants observed each 
session and completed the described measure. Tests of reliability were run to examine internal 
consistency as well as inter-rater reliability. Analyses of reliability demonstrated questionable-
acceptable (α= .48-.78) internal consistency and a wide range of very low to moderate intraclass 
correlation coefficients (3, 1) =.22-.79 for inter-rater reliability. These results demonstrated that 
raters varied in agreement throughout sessions of MF-PEP, implying the measures may be 
unclear or raters may need additional training to increase reliability. Varied levels of internal 
consistency also indicated that revisions may be needed in order to ensure that the measures are 
consistently measuring therapist adherence.   Measures with inconsistent reliability need 
additional revisions and research in order to be used to monitor treatment fidelity. This will 
enable comprehensive evaluations of empirically supported treatments, contributing to their 
effective and efficient use in clinical settings in order to create better client outcomes.  
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Development of Treatment Adherence Measures for Multi-Family Psychoeducational 
Psychotherapy (MF-PEP) for Children with Autism Spectrum Disorders 
Introduction 
Autism Spectrum Disorders: Diagnoses, Symptoms and Treatments  
Autism-Spectrum Disorders, or ASDs, are a group of developmental disorders 
characterized by three categories of impairment: social impairment, communication impairment, 
and restrictive, repetitive behaviors and interests.  Researchers view them as a spectrum because 
many symptoms present differently and with varying levels of severity in different children. The 
spectrum currently includes Autistic disorder, Asperger’s Disorder, and Pervasive 
Developmental Disorder Not Otherwise Specified (PDD NOS). ASDs affect about 1 in 88 
children, a number that has increased greatly over time (“Prevalence of Autism,” 2012). 
Researchers are unsure as to whether this increase is due to an actual increase in number of cases 
or an increase in the ability to diagnose the disorder. This rising number may also be attributed to 
the range of diagnoses included in an Autism-Spectrum Disorder diagnosis. Because ASD is an 
umbrella category, diagnosing a child with a specific disorder can be difficult.  While an 
individual with “classic Autism” usually displays significant deficits in all three categories, 
individuals with Asperger’s Disorder syndrome or PDD NOS may not display obvious 
impairment in all three of these categories (“Prevalence of Autism,” 2012). These impairments 
cause many unique challenges for children and their families with an ASD.  They can range from 
cognitive difficulties, trouble making and keeping friends, or emotional dysregulation at school 
and at home.  
Just as the type and severity of impairments faced by children with ASD varies, the 
treatments for children with an ASD also vary depending on the severity and type of diagnosis. 
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Behavioral therapy has received the most evaluation; typically, treatment goals are to increase 
productive behaviors and decrease unwanted ones. In addition, speech-language therapy, 
occupational therapy and physical therapy have been used in treatment. An additional treatment 
option is medication. While there are no medications that cure an ASD, there are options that can 
help families manage some of the symptoms associated with ASD. Finally, education-based 
treatment is an option that works to integrate the role of the child’s school into their treatment as 
well as provide resources for the family. It is recommended that treatments begin when a child is 
diagnosed, most commonly around age 3 (National Institute of Mental Health, 2011).  
While there are multiple options for treatment, many of which are supported by evidence, 
there is much room for improvement. There are many misconceptions about the origins and 
treatment options for children with an Autism Spectrum Disorder. Popular media coverage has 
falsely implicated vaccines as playing a role in causing Autism. These assertions alarmed 
parents, leading some to choose not to have their children vaccinated. Multiple studies have 
demonstrated that there is no link between vaccines and Autism (Immunization Safety Review 
Committee, 2004; Interagency Autism Coordinating Committee, 2010).  Additionally, many 
treatments involving changes to diets and unsupported therapeutic techniques are being used by 
parents of children with an ASD. A recently popular option for treating children with an ASD is 
a gluten-free, casein-free diet. While some studies have shown improvement in certain symptoms 
of ASD after following such a diet, this option has not been empirically supported and is not 
reliable for every child (Patel & Curtis, n.d.). Another controversial treatment method is a form 
of therapy known as sensory-integration therapy, a type of occupational therapy (OT) that 
involves challenging all of the senses. A literature review (Vargas & Camilli, 1994) demonstrated 
that the treatment was not effective overall. While this method has also not been backed by 
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research, many people still view it as a valid form of treatment. These misconceptions about the 
validity and effectiveness of treatment options only provide further support for the importance of 
empirically supported treatments (Vargas & Camilli 1994). Research has demonstrated that there is 
a need for additional evidence-based psychosocial interventions designed to help children and 
their parents with the symptoms and challenges of ASD, especially for children older than six 
(Warren, Z., Veenstra-VanderWeele, J., & Stone W. et al., 2011).  
Evidence-Based Practice 
Significant efforts have been made in recent years to bridge the gap between research and 
practice. The clinical use and successful replication of evidence-based practices, such as those 
being used to help children and their parents with the challenges of ASD is an effective way of 
beginning this process. This will not only serve the larger goal of merging research and practice 
but also improve daily functioning for children with an ASD diagnosis. Using evidence to inform 
practice (empirically-supported treatments) has become the preferred choice of treatment adapted 
for clinical use. This movement towards empirically-supported treatments originates from 
various sources, including the lack of funding for clinical services as well as the ease of 
implementing treatment and tracking effectiveness (Long, 2008).   
The American Psychological Association defines Evidence Based Practice for 
Psychology as the integration of the best available research with clinical expertise in the context 
of patient characteristics, culture, and preferences (American Psychological Association, 2002). 
This typically includes the integration of three principles.  First, decisions regarding 
interventions are backed by empirical, research-based support. Second, critical assessments are 
necessary to determine how well the EBP’s are suited to the intended practice. Third, regular 
monitoring and revisions are performed based on the outcome evaluation (Proctor & Rosen, 
Development of Treatment Adherence 9 
 
2004). Researchers continue to develop new interventions for various mental health issues, 
including treatment for alcohol addiction, adolescent depression, or development of school 
interventions and treatment for children with autism. 
The Importance of Evaluating Treatment Fidelity 
When using new psychosocial interventions, it is essential to monitor the in use 
treatments to insure successful development and implementation. While it is necessary to 
monitor multiple aspects of psychosocial interventions, one of the most commonly assessed 
aspects is treatment fidelity. Treatment fidelity encompasses adherence, differentiation, and 
competence. Adherence refers to evaluating whether the treatment was implemented as it was 
intended. Differentiation evaluates the degree to which one treatment can be distinguished from 
another while competence is the quality or skill with which interventions are delivered 
(Perepletchikova, 2005). The importance of fidelity in the evaluation of evidence-based practices is 
to guide the implementation process and assure the successful replication of the core principles 
and procedures in hopes that replication will achieve similar outcomes as the original research 
(Bond, Becker, & Drake, 2011). While all three aspects of fidelity are important, the current 
study examined only one aspect, treatment adherence.  
In addition to ensuring that research is being carried out as intended, fidelity 
measurements are vital to several other aspects of evidence-based practices. If any aspect of 
treatment fidelity is not assessed correctly, or not assessed at all, it will be more difficult to 
interpret the results of the study. A positive outcome or significant results may not be reliable 
because it will be impossible to determine whether they are a result of the intended treatment or 
an outside variable. Similarly, a failure to support the hypothesis may be due to improper 
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implementation or external factors (Dumas, Lynch, Laughlin, Smith, & Prinz, 2001; Schoenwald 
et al., 2010; Moncher & Prinz, 1991).  
Treatment fidelity must be assessed in these studies to maintain both internal (the degree 
to which observed effects can be attributed to the experimental treatment or condition), and 
external validity (the degree to which the findings can be generalized or applied to the real 
world). Maintaining external validity is necessary in order to perform treatment replication and 
apply treatments to a clinical setting. This brings the importance of treatment fidelity back to its 
larger purpose of assisting to merge research with applied setting practice.  
The current literature on treatment fidelity shows that it is largely neglected among 
research studies although the situation is improving slowly over time. From 1980-1994, one 
study reported that only 24% of 162 studies which evaluated effectiveness of prevention 
programs assessed fidelity (Dane & Schneider, 1998). The data on treatment program fidelity are 
only slightly higher. From 1968 to 1980, data collected on 539 studies in behavioral analysis 
demonstrated that only 20% contained any aspects of treatment fidelity (Peterson et al., 1982).   
One of the most comprehensive studies on the topic of treatment fidelity was completed 
by Moncher and Prinz (1991), who examined 359 treatment outcome studies for the existence 
and aspects of fidelity. They reviewed how fidelity was assessed and used in the interpretation of 
results as well as specific procedures used to promote fidelity. The study demonstrated that while 
the majority of research studies did not use any form of treatment fidelity (55%), treatment 
fidelity increased over the decade for studies using a manual, treatment supervision, and 
adherence checks (Moncher & Prinz, 1991). Minimal research in recent years has examined 
fidelity implementation. While many researchers report that they took certain precautions to 
promote fidelity, there is no record of the methods used to develop and assess treatment fidelity 
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(Dusenbury et al., 2003).  The degree to which fidelity has been neglected in the past is 
discouraging due to its importance in the success of evidence-based practice, but the increase 
over the last decade demonstrates that researchers are becoming more aware of its significance. 
In addition to the absence of treatment fidelity, even when studies do have some form for 
treatment fidelity, they rarely evaluate the reliability or validity of the measures used to assess 
fidelity. Scheirer and Rezmovic (1983) demonstrated an example of this when they reviewed 74 
studies that attempted to monitor fidelity and found that 65% of the studies didn’t discuss 
psychometric properties of the treatment fidelity instruments. Psychometric evaluation of fidelity 
measures is important to the effective implementation of treatment fidelity and will be further 
discussed in the next section.  
Assessing Treatment Fidelity  
To be effective, a fidelity measure should maintain certain psychometric properties. The 
science of psychometrics is usually focused on the type, reliability, and validity of the data. If a 
measure or test is psychometrically sound it will be reliable and useful in future research (Furr & 
Bacharach, 2008). Bond et al. (2011) evaluated psychometric properties of fidelity measures 
under the constraints of reliability and validity. Reliability measures consistency or repeatability, 
while validity describes whether a measure does what it is intended to do. There are various 
forms of reliability and validity designed to serve distinct purposes. Three types of validity are 
internal and external and concurrent validity. Three types of reliability are inter-rater and test-
retest reliability and internal consistency. Researchers employ some combination of these tests to 
ensure their measures are psychometrically sound. Psychometrically sound measures can be used 
to measure treatment fidelity of an empirically supported-treatment, such as the one discussed in 
subsequent paragraphs.  
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Multi-Family Psychoeducational Psychotherapy (MF-PEP) 
The Ohio State University has partnered with Nationwide Children’s Hospital to explore 
a new application of Multi-Family Psychoeducational Psychotherapy (MF-PEP), an evidence-
based intervention program developed by Dr. Mary Fristad, which combines psychoeducational 
properties (e.g., teaching about the disorder and its treatment) with psychotherapy (e.g., teaching 
communication, problem solving and emotion regulation skills) to improve children’s 
functioning in the home, at school and with peers. While MF-PEP was originally developed to 
target symptoms of mood disorders, it has been adapted for children with Autism Spectrum 
Disorders (ASD) and their families. In the pilot study of MF-PEP for ASD, positive treatment 
outcome results from both the child group and parent group evaluation were reported in most 
categories, as well as a substantial amount of positive qualitative feedback from parents and 
children (Fristad et al., 2009).  Additionally, past studies on MF-PEP for children with mood 
disorders showed promising results, suggesting lower mood symptom severity and improved 
family functioning at follow up (Mendenhall et al., 2009; Fristad et al., 2003). The larger current 
study being conducted on MF-PEP hopes to demonstrate that participating in MF-PEP for ASD 
will lead to better social adjustment, improved behavior, and an increased understanding of the 
diagnosis and challenges that accompany it 
The Current Study 
Developing evidence-based treatments for children with autism is important. Monitoring 
treatment fidelity should be part of this process. Successful evaluation of the properties of the 
adherence aspect of fidelity measures will contribute to the overall success of the intervention 
study for children and their families with an ASD and contribute to the overall field of research 
in psychology by continuing to merge the worlds of research and practice. The purpose of this 
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study was to examine the development, implementation and interpretation of treatment 
adherence measures designed to assess the effectiveness of a psychosocial intervention designed 
for children with Autism Spectrum Disorders and their families. More specifically, psychometric 
properties were assessed, including inter-rater reliability and internal consistency of the 
adherence measures. Adherence measures were hypothesized to be psychometrically sound and 
effective. Specifically, α coefficients were expected to be in the range of acceptable-excellent 
and intraclass-correlation coefficients (ICC) were expected to have moderate-strong agreement. 
Commonly accepted parameters for describing internal consistency using Chronbach’s alpha is 
as follows:  ≥ 0.9, Excellent, ≥ 0.8, Good, ≥ 0.7 Acceptable, ≥0.6, Questionable, ≥0.5, Poor, and 
< 0.5 Unacceptable (George & Mallery, 2003). If the measures are successfully implemented, it 
ensures that therapists adhere to guidelines set forth in the manuals and guarantee that the 
interpretation of results may be attributed to the intervention rather than outside variables.  
Methods 
Participants 
Participants were recruited every three months from families who were either existing 
patients at the Center for Autism Spectrum Disorders (CASD) or who contacted CASD based on 
the website and other standard advertisements for CASD group services offered through 
Nationwide Children’s Hospital. Approximately 6-8 families were recruited per session with 14 
families total completing the program during the Fall 2011 and Winter 2012 groups. To 
participate in the study, the families must have a child between the ages of 8-12 with an 
Aspergers or PDD-NOS diagnosis, as determined by the Autism Diagnostic Observation 
Schedule (ADOS), with a full scale IQ of at least 70. The families also needed to speak English.  
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A total of 13 children participated in the study, six from the Fall 2011 group and seven 
from the Winter 2012 group. The Fall 2011 group consisted of three males and three females 
while the Winter 2012 group consisted of seven males. Thus, combined, the sample included ten 
male children (76.9%) and three female children (23.1%). All participants self-identified as 
white and not Hispanic. Demographics of the sample were consistent with the 2012 report from 
the Center for Disease Control and Prevention that found significantly higher prevalence of ASD 
amongst boys than girls and amongst non-Hispanic white children than non-Hispanic black 
children and Hispanic children (Center for Disease Control and Prevention, 2012).  
Researchers obtained children’s IQ scores and diagnostic information from their 
assessments with their psychologists. Full Scale Wechsler Intelligence Scale for Children 
(WISC) scores were obtained from seven out of 13 children, with a mean score of 94 (range, 72 
to 130). Full Scale Stanford-Binet Intelligence Scale (SB-5) scores were obtained from five 
children, with a mean score of 94.8 (range, 81 to 113). A Full Scale Wechsler Preschool and 
Primary Scale of Intelligence (WPPSI) score was attained from one child with a score of 81. 
Children had a variety of clinical diagnoses on the autism spectrum. Eight participants 
had a primary diagnosis of Pervasive Development Disorder- Not Otherwise Specified (PDD-
NOS), four participants had a primary diagnosis of Asperger’s Disorder, and one participant had 
a primary diagnosis of Autistic Disorder. In addition to primary diagnoses, six participants had 
comorbid diagnoses. Five participants had a comorbid diagnosis of ADHD and one had a 
comorbid diagnosis of Disorder of Written Expression. Two participants had secondary 
comorbid diagnoses of Learning Disorder – Not Otherwise Specified and Oppositional Defiant 
Disorder. One participant had a third comorbid diagnosis of depression.  
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Because measurement development is the primary goal, raters filling out the measures 
were also participants in the study. Two undergraduates and one graduate level student 
completed rating measures throughout the sessions. All three raters had training from observing 
previous groups of MF-PEP as well as training in the measures and coding procedures. Rater A 
rated sessions 1-8 of the Fall group, Rater B rated sessions 1-8 of both the Fall and Winter 
groups, and Rater C rated sessions 1-8 of the Winter group. Parents gave written consent and 
children written assent to participate in assessments and treatment. All study procedures and 
measures were approved by Nationwide Children’s Hospital’s Institutional Review Board (IRB), 
which has reciprocity with The Ohio State University IRB. 
Measures 
The adherence measure for the Child Group from the existing MF-PEP for mood 
disorders intervention (Therapist Adherence Checklist Child; Leffler, MacPherson, & Fristad, 
2010) was adapted for the MF-PEP for ASD groups. The Parent Group Adherence Checklist was 
not available at the time of data collection for the current study, but will be adapted for use with 
the ASD groups in a future study. The checklists were adapted by altering items referring to 
mood disorders and changing them to fit the topics applicable for children with an ASD. An 
example of an item on one of the measures is: “asked members to rate their feelings and share 
with the group.”  The corresponding total percentage completed as well as number of items was 
adapted as the number of items increased or decreased. The adapted MF-PEP for ASD Therapist 
Adherence Checklist, Child Version (see Appendix A) are a series of checklists with 18-45 items 
that assess the degree to which the therapists leading the sessions adhered to the procedures 
outlined in the MF-PEP parent and child session manuals. Procedures of interest included 
reviews of past topics, introduction of new concepts, and other specific activities from the 
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manual. The measure evaluated for these sessions was the Therapist Adherence Checklist Child 
Version.  
Procedure 
Originally designed for children with mood disorders, MF-PEP has been adapted for 
children with ASD and their families. The program, still in the early stages of development, was 
implemented over 9 weekly sessions during which parents and children received education and 
social support, and developed skill sets including problem-solving, emotional regulation, and 
communication skills. Families participating in the study completed baseline assessments, 
attended eight sessions of MF-PEP, and completed post-treatment assessments. Each session 
covered a topic related to living with and overcoming the obstacles associated with ASD. Parent 
and child sessions were run separately, with the two groups meeting briefly at the end of each 
session to review what was learned. Two trained bachelor’s level facilitators co-led the child 
group and covered topics such as non-verbal and verbal communication, emotional awareness 
and regulation exercises, and coping strategies related to common problems associated with 
ASD. The parent group was facilitated by an experienced Ph.D.-level psychologist and topics 
covered included treatment teams, medications, accommodations for a school setting, and other 
strategies for improving functioning at home.   
To assess treatment adherence, trained undergraduate and graduate research assistants 
attended, observed, and took notes on each of the MF-PEP sessions. Multiple raters were used 
for the purpose of establishing inter-rater reliability. Raters noted whether facilitators included 
the appropriate educational and discussion topics and accompanying activities for each session. 
The measures were completed each week by the trained raters with a scoring system of 0 = not 
present, 1 = present, or X = can’t rate (due to limitations), with space for comments. An example 
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of a possible limitation is a rater leaving the room, being unable to hear the facilitator, or 
attending to a child in the group. Data were collected from the Fall 2011 and Winter 2012 MF-
PEP groups.  
Data Analysis 
Adherence measures were analyzed internal consistency and inter-rater reliability. 
Internal Consistency was assessed by calculating Coefficient α.  Inter-Rater reliability was 
assessed two ways. First, Kappa was used. Second, Intraclass Correlation Coefficients, or the 
degree of agreement among raters, was also used as it is particularly useful when assessing 
dichotomous data. 
Individual items for each session were summed. The scores were then divided by the total 
number of items on the measure to obtain an overall percentage for each session. Items that had 
only one rater’s response were dropped and the N was adjusted accordingly.  
     Results 
Internal Consistency 
 Overall measures of internal consistency were obtained for each session (1-8) by 
combining both Fall and Winter groups of MF-PEP using the Therapist Adherence Checklist-
Child Version. The individual sessions’ alphas ranged from α=.48 to .78 (Table 1). One session 
showed acceptable (α >.7) internal consistency while the majority of the rest had questionable (α 
>.6) ratings (George & Mallery 2003).   
Inter-Rater Reliability 
Preliminary analyses were conducted on the data to determine Kappa, a measure used for 
inter-rater reliability. For the fall session, Week 1 Kappa= .55, Week 2 Kappa=.79; Week 3 
Kappa=.69; Week 4 Kappa=.62; Week 5 Kappa=.44; and Week 6 Kappa= .35. Due to scheduling 
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conflicts, the sessions during weeks 7 and 8 were combined into a final session with Kappa=.27. 
Results for the winter session were as follows: Week 1 Kappa=.62; Week 2 Kappa=.22; Week 3 
Kappa=.61; Week 4 is missing data; Week 5 Kappa= .30; Week 6 Kappa=.44; and Week 7 
Kappa=.39. For Week 8, neither raters were able to attend so there were no data for that session.  
Using the standard for interpretation of agreement when using Kappa, the data from the 
Fall Session includes 3 weeks with substantial agreement between raters, 2 weeks with moderate 
agreement, and only 1 week with fair agreement. The winter session showed 2 sessions with 
substantial agreement, 1 week with moderate agreement, and 2 weeks with fair agreement 
(Landis & Koch, 1977). Further analyses were run to examine internal consistency and inter-
rater agreement. 
Inter-rater Reliability  
Further measures of reliability were obtained from the three raters by calculating the 
intraclass correlation coefficients (ICC). A two-way mixed single measures model was used 
where inferences were confined to this particular set of raters in the measurement process. This 
model was chosen because raters were exactly 3 raters, 2 of whom rated each item in a session, 
making the raters a second factor in a two way ANOVA model.  At a .95 confidence interval, 
ICCs for the Fall group ranged from ICC (3, 1) = .32-.79 (See Table 2). This demonstrates a 
wide range of reliability from very low agreement/low reliability to moderate agreement/good 
reliability. Due to scheduling conflicts sessions 7 and 8 were combined into a final session, 
possibly affecting the inter-rater agreement. ICCs for the Winter group ranged from ICC (3, 1) = 
.22-.66; again presenting a drastic range in reliability from very low to moderate. When looking 
at the overall inter-rater agreement for the Fall group it was found that ICC (3, 1) = .56; while the 
overall statistic for the Winter group was ICC (3, 1) = .44. The discrepancies between Fall and 
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Winter groups also imply raters during the Fall group had higher overall agreement than the 
Winter group.  
Discussion 
 It was hypothesized that the Therapist Adherence Checklists-Child Version would be 
psychometrically sound and reliable, enabling them to be put to future use effectively measuring 
the fidelity of MF-PEP for children and their families with an ASD. More specifically, internal 
consistency was expected to demonstrate acceptable-excellent reliability and intraclass 
correlation coefficients were expected to demonstrate strong-moderate agreement, implying 
good-very good reliability. The hypothesis regarding internal consistency was not fully 
supported as the measures had moderate to poor reliability.  
Implications 
 As there are no standardized measures that are designed to assess similar constructs, these 
results imply that development of adequate adherence measures are still in early stages. The need 
for specificity for these adherence measures presents problems that may not have arisen with a 
more general standardized measure. There is no reference point to compare the measure with, 
making it difficult to evaluate other aspects of validity such as discriminant or convergent 
validity (used to measure the degree to which measures are similar or different to other measures 
designed to assess the same/different constructs). Overall, these results demonstrate the need for 
additional research in areas of adherence measure development. As mentioned previously, 
understanding multiple aspects of implementing treatment fidelity, such as measurement and 
analysis of adherence measures, identifies the aspects that support or hinder successful 
implementation. Consequently, establishing the reliability and validity of fidelity measures 
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enables developing group-based interventions, such as the one used in the current study, to 
continue to progress (Zvoch, 2009). 
The large range in internal consistency coefficients raises concerns about the Therapist 
Adherence Checklist-Child Version’s ability to assess fidelity for that session. While a rating of 
questionable may be acceptable for exploratory research, measures should have acceptable or 
higher ratings to be considered psychometrically sound. These discrepancies imply that the 
measures can’t be considered consistent in measuring therapist adherence and need 
modifications before future use. After examining the sessions with the lowest internal 
consistencies, it is possible to conclude that the material these sessions cover may be more 
complex and greater in quantity than other sessions. As the group data were combined, Session 8 
internal consistency is likely low as one group was unable to attend so data were only available 
for the Fall Session. Also, as the group progresses through the sessions, the material changes 
slightly as it includes additional material to review. This range may also be attributed to the large 
variability in items of interest measured from session to session. This should be taken into 
consideration when adapting future measures in order to improve reliability. Additionally, after 
re-examining internal consistency, it is worthwhile to consider how applicable this measure is to 
the reliability of the Therapist Adherence Checklist. While internal consistency has been 
measured in past literature on treatment adherence, it is more applicable when the measure is 
developed with a Likert-type scale as there is more variability in scores. Also, as internal 
consistency examines the extent to which items on a measure assess the same construct, the 
Therapist Adherence Checklist-Child Version’s variability in types of items present throughout 
one session may have played a role in the inconsistency of results; indicating that examining 
internal consistency is not as applicable as hypothesized.  
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The second measure of reliability examined, inter-rater reliability, also produced 
inconsistent results. Similar to internal consistency, while some sessions displayed high inter-
rater agreement, others showed poor reliability in the low agreement range between raters. It can 
be assumed that while the inter-rater agreement varied from session to session, there was a 
moderate amount of disagreement between raters during the groups. Also, agreement between 
raters during the first group was on average higher than the second group. The differences in 
agreement across sessions could be due to a number of factors. Examining the sessions with the 
lowest agreement provide possible explanations for lack of agreement. Raters had to briefly 
leave the room during one session to assist with an additional survey. Additionally, sessions with 
lower agreement have fewer items on them than others. For both measures of reliability, 
completing the measures for additional sessions with additional raters would provide a more 
accurate estimate of the data.  Despite the measures failing to support the hypotheses, these 
findings do provide implications for the field of psychometrics and from the broader standpoint 
of treatment fidelity. As mentioned previously, fidelity has largely gone unrecognized in recent 
years and is only recently becoming an issue research has come to address. This makes it more 
difficult to create accurate and reliable measures to assess treatment fidelity, or more 
specifically, treatment adherence.  
Limitations 
 There were a number of limitations that could have impacted the results of this study. 
First, a few factors affected the ability of raters to accurately complete the adherence measures. 
Due to the nature of the symptoms and challenges associated with the population being studied 
(children with an ASD), occasionally situations would arise where raters would need to exit the 
room briefly with a child for a break due to behavioral or other reasons. This would impair their 
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ability to continue to complete the measure while the other rater would still be able to.  These 
items would be discarded from analysis, lowering the N value. Another limitation stemming 
from the demographics and format of the group is the effect that the number of children present 
in the group would have on the therapists and raters. If the therapists needed assistance keeping 
the children focused, they would occasionally ask a rater to help; thus temporarily impairing 
their ability to fill out the measure. The number of children in a group also contributed to the 
level of distraction throughout the session, possibly impeding a rater’s ability to hear the material 
covered by the therapists.  These aspects impeding data collection would impact inter-rater 
reliability because one rater would be recording different things than the other. This limitation is 
difficult to control simply because they are due to the format of the group and this is unable to be 
changed. One possible idea would be to have three raters in each group to increase the amount of 
data collected; making it more reliable, or designate a specific therapist helper to decrease the 
amount of assistance asked of the raters. Additional training for raters or having raters observe 
from a recording of the session may also increase inter-rater reliability as any discrepancies 
could be explained beforehand.  
 Additional limitations are related to the amount of data available for analysis. While up to 
8 children can participate in a group of MF-PEP, only one rating each week is possible due to the 
group format. Additionally, the groups run one at a time, in 8-week sessions, making it difficult 
to collect large amounts of data without spending an extended period of time in multiple groups. 
This impacts both measures of reliability as more data would increase power, therefore 
increasing reliability. Further research will incorporate additional groups and look at effects over 
time.  
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It is also important to acknowledge potential limitations when establishing therapist 
adherence of the groups. The format of the group is the main limitation in this area. When 
evaluating the results of the measures in the future certain factors such as the number of 
instructors, number of children, as well as length of time for each group should be considered. 
Additionally, the amount of material necessary to cover for each session should be taken into 
account as it may be more difficult to get through some weeks than others.  
Future Directions 
 The current study raises quite a few additional questions and allows for a variety of 
modifications to be made in order to continue to research this topic. The first change that should 
be made for future research is in revising the current measures to continue to evaluate treatment 
adherence for the child group of MF-PEP for ASD. Focusing specifically on the measures with 
the lowest inter-rater reliability and internal consistency, the measures should be re-worked 
according to the manual by adjusting the criteria for certain items, thereby clarifying them for 
future raters.  It may also prove worth it to look into running additional, more applicable 
statistics in order to get a more accurate picture of the measures’ reliability. It will then be 
necessary to continue to collect data for the child group and re-evaluate the reliability as well as 
look into validity in order to produce the most accurate, reliable measure possible.  
 After finalizing the Therapist Adherence Checklist-Child Version, it will be important to 
develop a corresponding measure for the parent group. It will be interesting to determine whether 
the results are similar or different from the child group results.  Once both measures are 
psychometrically sound then research can focus on analyzing the results of the Therapist 
Adherence Checklists and evaluating how treatment fidelity impacts the outcome of the 
intervention.  
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Measuring adherence and assessing this aspect of treatment fidelity of both the parent and 
child group would be another step to advance this research. After it is determined the measures 
are reliable and valid, they can be used for their intended purpose and data on the therapist 
adherence checklists can be calculated. After additional data collection, the level of therapist 
adherence can be calculated and discussed, with feedback provided to both the parent and child 
group leaders as a reminder to cover topics mentioned in the manual. This will be important to 
know for the effectiveness of MF-PEP as a larger study. It will be important to examine how 
treatment outcome and treatment adherence interact. This would be an additional aspect to look 
at in the future. If the therapists have high adherence, positive or negative outcomes of MF-PEP 
can be attributed to the therapy itself and not some confounding variable.  
As more clinicians adopt evidence based practice as the primary mode of treatment, they 
will need as much information as possible regarding the content and fidelity from the researchers 
in order to implement the treatment effectively. Treatment adherence can serve a number of 
other purposes including providing a standard for which all future treatments should be held, 
reducing costs by promoting early detection of errors, and providing necessary evidence for 
important choices made by researchers and organizations such as funding needs and employment 
decisions (Moncher & Prinz, 1991; Schoenwald, 2011).  
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Appendix A 
 
MF-PEP Therapist Adherence Checklist 
Child Session 1: Symptoms & Medications 
 
Specific Activities Score 
0=Not present 
1=Present 
X=Can’t rate* 
Comments 
Initial Intro and Check-In  
1 Introduced self and provided time for families to 
introduce themselves 
  
Intro and Check-In with Children 
2 Did an icebreaker   
3 Introduction to and purpose of the group   
4 Reviewed benefits of the group   
Orientation to the group 
5 Covered length of the group   
6 Covered format of the group   
Confidentiality 
7 Introduced topic of confidentiality   
8 Gave concrete example of confidentiality   
Group Rules 
9 General (discuss)   
10 Specific (list)   
Rewards/Points 
11 Explained immediate rewards   
12 Explained long-term points and how to redeem   
Distribution of Child Manuals 
13 Explained all materials are in this manual   
14 Client is responsible for bringing it to every session   
15 Covered the topic of weekly projects   
Identifying and Rating Feelings 
16 Asked members to identify and rate feelings    
17 Explained “danger zone” and goal for the activity   
18 Shared feelings and intensity with group and 
identified reason for choice 
  
19 Engaged members to share their feelings and 
intensity with group along with reason for choice 
  
Session 1 Preview 
20 Presented all 3 content areas of preview   
What are Autism Spectrum Disorders 
21 Generate list of ASD problem areas     
22 Review problems associated with ASD in Child 
Workbook  (general) 
   
 
23 Review problems associated with perseveration   
24 Review problems associated with emotional 
regulation 
  
25 Review problems associated with social isolation   
Other Problems 
26 Identified additional disorders that might be   
Development of Treatment Adherence 35 
 
experienced by members 
27 Briefly reviewed symptoms of additional disorders   
MF-PEP Motto 
28 Introduced motto and had members state it    
29 Explained motto and its goal in the group   
“Fix It” List Project 
30 Asked members to describe a time when ASD 
symptoms caused trouble in each of the areas 
  
31 Reviewed “Fix It” list example   
32 Explained instructions of project   
33 Inquired about and problem solved potential 
barriers to completing the project 
  
Physical or Active Learning Project 
34 Explained and demonstrated the project’s goal    
35 Discussed how the activity ties into group topic   
Belly Breathing 
36 Explained importance of breathing exercises and 
how they factor into group goals and/or motto 
  
37 Reviewed physiology of deep breathing   
38 Explained and modeled breathing exercise ≥ 2 
times 
  
39 Provided feedback to group and/or specific 
members about their breathing 
  
40 Explained goal of practicing daily or, at minimum, 
3X before next session; record practice in their log 
  
Volunteers 
41 Selected volunteer to explain session topics   
42 Selected volunteer to explain the “Fix It” list project   
43 Selected volunteer to demonstrate and explain 
belly breathing 
  
Rejoined Parent Group 
44 Had three volunteers share their information with 
the parent group; and provided assistance as 
needed 
  
45 Reminded parents and children to bring their 
workbooks back each week 
  
 
Total:    
Total X items:   
Percent [Total Divided by (45 – number of X items) * 
100]: 
  
*Can’t rate due to technical limitations (e.g., tape review--recording unclear, live observer-- had to leave room) 
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MF-PEP Therapist Adherence Checklist 
Child Session 2: Naming the Enemy & Medications 
 
Specific Activities Score 
0=Not present 
1=Present 
X=Can’t rate* 
Comments 
Check-In  
1 Encouraged families to briefly reintroduce 
themselves  
  
2 Engaged a few members/families to briefly share 
their Week 1 project 
  
Identifying and Rating Feelings 
3 Asked members to identify and rate their feelings    
4 Reviewed, as needed, how to complete and activity’s 
goal 
  
5 Shared feelings and intensity with group and 
identified reason for choice 
  
6 Engaged members to share their feelings and 
intensity with group along with reason for choice 
  
Session 2 Review/ Preview 
7 Gave each member a chance to share News of the 
Week 
  
8 Awarded points   
9 Reviewed members’ Week 1 project   
10 Addressed concerns related to difficulty 
understanding or completing the project 
  
11 For the following review, all shaded items should be 
briefly covered to be present 
 NOTE: Tally only #11, not 11a-
e for final score 
11a Reviewed group rules 1        0       X  
11b Reviewed problems of ASD 1        0       X  
11c Reviewed the family “Fix-It” list of goals to achieve by 
the end of group 
1        0       X  
11d Reviewed MF-PEP motto 1        0       X  
11e Reviewed breathing techniques 1        0       X  
12 Previewed topics for Week 2   
Naming the Enemy 
13 Discussed positive personal characteristics   
14 Facilitated generating a list of symptoms and positive 
personal characteristics 
  
15 Demonstrated how symptoms can cover positive 
personal characteristics 
  
16 Demonstrated how managing symptoms can allow 
positive personal characteristics to be uncovered 
  
Getting Help 
17 Identified and explained how educational services 
can assist in symptom management 
  
18 Identified and explained how therapy services can 
assist in symptom management 
  
19 Identified and explained how discussing medications 
and side effects with the prescriber can assist in 
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symptom management 
Connections between Treatment and ASD Problems 
20 Explained how to evaluate effects of each 
intervention 
  
21 Discussed role of a treatment team and how to 
successfully participate as part of the team 
  
My Medicine Worksheet 
22 Encouraged members to complete worksheet   
23 Facilitated members to share medication information   
24 Discussed enemies targeted by medications and 
potential barriers related to medications 
  
25 Identified the potential role of medication in treating 
ASD 
  
Side Effects and Treatments 
26 Introduced and discussed pros/cons of medications    
27 Explained side effects and discussed ways to 
address them  
  
28 Distinguished between unpleasant and serious side 
effects 
  
29 Encouraged members to communicate with 
caregivers and prescribers about their medication 
side effects and concerns 
  
“Naming the Enemy” The Symptom-Self Exercise Project 
30 Explained project instructions using examples from 
group 
  
31 Inquired about and problem solved potential barriers 
to completing the project 
  
Physical or Active Learning Project 
32 Explained and demonstrated the project’s goal    
33 Discussed how the activity ties into group topic   
Bubble Breathing 
34 Explained and modeled breathing exercise ≥ 2 times   
35 Provided feedback to group and/or specific members 
about their breathing 
  
36 Explained goal of practicing daily or, at minimum, 3X 
before next session; record practice in their log 
  
Volunteers 
37 Selected volunteer to explain session topics   
38 Selected volunteer to explain the ”Naming the 
Enemy” project 
  
39 Selected volunteer to demonstrate and explain 
breathing exercise 
  
Rejoined Parent Group 
40 Had three volunteers share information with the 
parent group; provided assistance as needed 
  
41 Encouraged parents and children to work on their 
breathing exercise and projects 
  
 
Total:    
Total X items:   
Percent [Total Divided by (41 – number of X items) * 
100]: 
  
*Can’t rate due to technical limitations (e.g., tape review--recording unclear, live observer-- had to leave room) 
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MF-PEP Therapist Adherence Checklist 
Child Session 3: Feelings Management 
 
Specific Activities Score 
0=Not 
present 
1=Present 
X=Can’t rate* 
Comments 
Check-In  
1 Engaged a few members/families to briefly share their 
Week 2 project 
  
Identifying and Rating Feelings 
2 Asked members to identify and rate feelings    
3 Shared feelings/intensity with group; identified reason for 
choice 
  
4 Engaged members to share their feelings and intensity 
with group along reason for choice 
  
Session 3 Review/ Preview 
5 Gave each member a chance to share News of the Week   
6 Awarded points   
7 Reviewed member’s Week 2 project    
8 Addressed concerns related to difficulty understanding or 
completing the project 
  
9 For the following review all shaded items should be 
briefly covered to be present 
 NOTE: Tally only #9, not 
9a-h for final score 
9a Reviewed group rules 1        0      X  
9b Reviewed problems associated with ASD 1        0      X  
9c Reviewed MF-PEP motto 1        0      X  
9d Reviewed the family “Fix-It” list of goals to achieve by the 
end of group 
1        0      X  
9e Reviewed how ASD problems and other disorders can 
result in negative feelings about self and affect their 
relationships with others  
1        0      X  
9f Reviewed treatment team members and how to be an 
active member of the team 
1        0      X  
9g Reviewed medications, common side effects, and how to 
manage side effects 
1        0      X  
9h Reviewed breathing techniques 1        0      X  
10 Previewed topics for Week 3   
My Triggers for Mad/Sad/Bad Feelings 
11 Explained mad, sad, and bad feelings   
12 Discussed that we can experience more than one feeling 
related to an event 
  
13 Explained triggers (ie, some event that leads you to feel 
mad, sad, or bad)  
  
14 Provided example of triggers   
15 Generated ideas of triggers with members   
16 Encouraged members to write down examples on “My 
Triggers for Mad/Sad/Bad Feelings” worksheet 
  
17 Discussed responses to triggers   
My Body Signals 
18 Explained how our bodies can react to our feelings with 
physiological sensations  
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19 Generated ideas about body signals of mad, sad, and 
bad feelings with group 
  
20 Used silhouette to indicate areas of physiological 
sensations 
  
21 Encouraged members to write down examples on “My 
Body Signals for Mad/Sad/Bad Feelings” worksheet 
  
My Actions when I Feel Mad, Sad, or Bad 
22 Summarized past discussion of triggers, events that 
trigger mad, sad or bad feelings, and how our bodies 
react to those feelings 
  
23 Explained we have choices about how we respond to our 
feelings 
  
24 Linked discussion back to group motto   
25 Explained three ways to evaluate whether an action is 
helpful or hurtful: 1) does it hurt me; 2) does it hurt 
anyone or anything else; 3) does it get anyone in trouble 
  
26 Encouraged members to write down examples on “My 
Actions when I Feel Mad/Sad/Bad” worksheet 
  
Taking Care of the Mad, Sad, Bad Feelings: Tool Kit Project 
27 Explained the goal of generating strategies to help better 
manage mood 
  
28 Explained this collection of strategies is called a “tool kit” 
because it holds the “tools” for activities that help 
manage moods 
  
29 Discussed importance of developing a variety of 
strategies that can be used at different places and times 
  
30 Discussed four categories of tools: 1) creative; 2) active; 
3) rest and relaxation; and 4) social 
  
31 Encouraged members to generate a list of activities in 
each category 
  
32 Explained instructions for completion of tool kit project   
33 Informed members that they can make an actual tool kit 
and bring it in to share next session and earn extra 
participation points 
  
34 Explained second part of project: writing down three 
events that upset members during the week; how their 
body felt when it happened; how they remembered to 
use their tool kit; the tools they used; and how the 
strategy worked 
  
35 Identified and problem solved any potential barriers to 
completing project 
  
Physical or Active Learning project 
36 Explained the activity’s goal    
37 Discussed how the activity ties into group topic   
Balloon Breathing 
38 Explained and modeled breathing exercise at least twice   
39 Provided feedback to group and/or specific members 
about their practice 
  
40 Explained goal of practicing daily or, at minimum, 3X 
before next session; record practice in their log 
  
Volunteers 
41 Selected volunteer to explain session topics   
42 Selected volunteer to explain the “Taking Charge of the   
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Mad, Sad, Bad Feelings” project 
43 Selected volunteer to demonstrate and explain balloon 
breathing 
  
Rejoined Parent Group 
44 Had three volunteers share their information with the 
parent group and provided assistance as needed 
  
45 Encouraged parents and children to work on their 
breathing exercise and projects 
  
 
Total:    
Total X items:   
Percent [Total Divided by (45 – number of X items) * 100]:   
*Can’t rate due to technical limitations (e.g., tape review--recording unclear, live observer-- had to leave room) 
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MF-PEP Therapist Adherence Checklist 
Child Session 4: Thinking, Feeling, Doing 
 
Specific Activities Score 
0=Not present 
1=Present 
X=Can’t rate* 
Comments 
Check-In  
1 Engaged a few members/families to briefly share their 
Week 3 project 
  
Identifying and Rating Feelings 
2 Asked members to identify and rate feelings    
3 Shared feelings and intensity with group and identified 
reason for choice 
  
4 Engaged members to share their feelings and intensity 
with group along with reason for choice 
  
Session 4 Review/ Preview 
5 Gave each member a chance to share News of the 
Week 
  
6 Awarded points   
7 Reviewed members’ Week 3 project   
8 Addressed concerns related to difficulty understanding 
or completing the project 
  
9 Allowed members to share their tool kits   
10 For the following review, all shaded items should be 
briefly covered 
 NOTE: Tally only #10, not 
10a-g for final score 
10a Reviewed how triggers affect our mood  1        0        X  
10b Reviewed when to apply coping strategies from tool kits 1        0        X  
10c Reviewed how to evaluate whether an action is helpful 
or hurtful 
1        0        X    
10d Reviewed how problems of ASD can result in negative 
feelings about self and affect their relationships with 
others 
1        0        X  
10e Reviewed members of their treatment team and how to 
be an active member of the team 
1        0        X  
10f Reviewed medications, common side effects, and how 
to manage side effects 
1        0        X  
10g Reviewed MF-PEP motto 1        0        X  
11 For the following review, ≥ 50% of shaded items should 
be briefly covered 
 NOTE: Tally only #11, not 
11a-d for final score 
11a Reviewed the family “Fix-It” list of goals to achieve by 
the end of group 
1        0        X  
11b Reviewed group rules 1        0        X  
11c Reviewed problems associated with ASD 1        0        X  
11d Reviewed breathing techniques 1        0        X  
12 Previewed topics for session 4   
Changing Thoughts, Feelings, and Actions: Hurtful Example 
13 Identified trigger (getting a bad grade) and associated 
feelings 
  
14 Identified and processed with members how those 
feelings helped or hurt them 
  
15 Discussed “doing” part by encouraging members to 
identify helpful and hurtful behaviors and their 
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associated outcomes 
 
16 Identified association between thoughts, feelings and 
behaviors 
  
17 Discussed the role of thoughts and difference between 
thoughts and feelings 
  
18 Engaged the members in identifying thoughts for this 
example 
  
19 Reviewed hurtful example and described steps to 
demonstrate cycle 
  
Changing Thoughts, Feelings, and Actions: Helpful Example 
20 Discussed why it might be important to change hurtful 
feelings, thoughts and behaviors to more helpful ones 
  
21 Identified how to evaluate outcome of actions   
22 Reviewed how MF-PEP motto should be incorporated in 
the model 
  
23 Engaged members in discussing helpful “doing” 
examples to use tools from tool kit 
  
24 Facilitated discussion of helpful thoughts members 
could have in this situation 
  
25 Explained how helpful thoughts can result in helpful 
feelings and actions 
  
26 Compared outcomes in helpful cycle and hurtful cycle   
27 Explained that hurtful thoughts and actions can result in 
hurtful feelings that continue a hurtful cycle that 
increases our negative feelings and thoughts about 
others, our environments, and ourselves 
  
28 Explained that we may experience hurtful feelings, but 
by changing to helpful thoughts and actions we can 
improve our feelings 
  
29 Explained how bidirectional arrows indicate that a 
change in one are impacts another 
  
Changing Thoughts, Feelings, and Actions: Group Specific Examples 
30 Facilitated discussion and provided feedback of trigger 
events for group members 
  
31 Facilitated discussion and provided feedback of hurtful 
thinking, feeling, and doing with identified triggers 
  
32 Facilitated discussion and provided feedback of helpful 
thinking, feeling, and doing with identified triggers 
  
Thinking-Feeling-Doing Project 
33 Reviewed steps of the Thinking, Feeling, Doing cycle 
and how to evaluate outcomes of the actions using 
workbook examples 
  
34 Explained instructions for completion of “Thinking-
Feeling-Doing” Project 
  
35 Identified and problem solved any potential barriers to 
completing project 
  
Physical or Active Learning Project 
36 Explained and demonstrated goal of the activity   
37 Discussed how the activity ties into group topic   
Belly Breathing 
38 Explained and modeled breathing exercise    
39 Provided feedback to group and/or specific members   
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about their breathing 
40 Reminded members about goal of practicing daily or, at 
minimum, 3X before next session; record practice in log 
  
  
Volunteers 
41 Selected volunteer to explain session topics   
42 Selected volunteer to explain the “Thinking-Feeling-
Doing” project 
  
43 Selected volunteer to demonstrate belly breathing   
Rejoined Parent Group 
44 Had three volunteers share their information with the 
parent group; provided assistance as needed 
  
45 Encouraged parents and children to work on their 
breathing exercise and projects 
  
 
Total:    
Total X items:   
Percent [Total Divided by (45 – number of X items) * 100]:   
*Can’t rate due to technical limitations (e.g., tape review--recording unclear, live observer-- had to leave room) 
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MF-PEP Therapist Adherence Checklist 
Child Session 5: Problem Solving 
 
Specific Activities Score 
0=Not present 
1=Present 
X=Can’t rate* 
Comments 
Check-In  
1 Engaged a few members/families to briefly share their 
Week 4 project 
  
Identifying and Rating Feelings 
2 Asked members to identify and rate feelings    
3 Shared feelings and intensity with group and identified 
reason for choice 
  
4 Engaged members to share their feelings and intensity 
with group along with reason for choice 
  
Session 5 Review/ Preview 
5 Gave each member a chance to share News of the Week   
6 Awarded points   
7 Reviewed members’ Week 4 project   
8 Addressed concerns related to difficulty understanding or 
completing the project 
  
9 For the following review, all shaded items should be 
briefly covered  
 NOTE: Tally only #9, not 
9a-e for final score 
9a Reviewed how thoughts, feelings, and behaviors are 
linked, each one affecting and being affected by the other 
two 
1        0        X  
9b Reviewed how we can transform hurtful/negative thoughts 
into more helpful/positive ones to change our feelings and 
behavior in a tough situation 
1        0        X  
9c Reviewed how triggers affect our mood 1        0        X  
9d Reviewed when to apply coping strategies from tool kits 1        0        X  
9e Reviewed MF-PEP motto 1        0        X  
10 For the following review, ≥ 50% of shaded items 
should be briefly covered 
  
10a Reviewed the family “Fix-It” list of goals to achieve by the 
end of group 
1        0        X  
10b Reviewed group rules 1        0        X  
10c Reviewed problems associated with ASD 1        0        X  
10d Reviewed how to evaluate whether an action is helpful or 
hurtful 
1        0        X  
10e Reviewed breathing techniques 1        0        X  
10f Reviewed how ASD problems can result in negative 
feelings about self and affect relationships with others  
1        0        X  
10g Reviewed treatment team members and how to be an 
active member of the team 
1        0        X  
10h Reviewed medications, common side effects, and how to 
manage side effects 
1        0        X  
11 Previewed topics for Week 5   
Problem Solving: Introduction with Group Member Example 
12 Identified a trigger provided by a group member (ie, an 
event that occurred and resulted in a hurtful feeling) 
  
13 Using member’s example, reviewed what happened next   
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14 Using member’s example, reviewed outcome of action 
and identify whether it was helpful or hurtful (does it hurt 
me; does it hurt anyone  or anything else; does it get 
anyone in trouble) 
  
Problem Solving: Introducing the Steps using Group Member Examples 
15 Explained identification of triggers using another group 
member example 
  
16 Identified, with group member’s input, a potential problem   
17 Identify the hurtful feeling and its intensity    
18 Generated with group members ≥ 2 coping strategies 
they could have used to calm down (STOP step) 
  
19 Generated with group members ≥ 3 options to better 
handle the situation (THINK step) 
  
20 Discussed with group members which options they would 
be willing to try (PLAN step) 
  
21 Restated the chosen option (DO step)   
22 Followed-up by asking “What would happen if you did 
this?  Would the outcome be helpful or hurtful?”  (CHECK 
step) 
  
23 Engaged members to discuss if they would use this 
strategy in the future (why/why not) 
  
24 Completed ≥ 1 more example of problem solving steps 
with another group member’s identified trigger 
  
25 Encouraged completion of Problem Solving worksheet   
Problem Solving Project 
26 Reviewed steps of the problem-solving approach and how 
to evaluate outcomes  
  
27 Explained instructions for completion of “Problem Solving” 
Project 
  
28 Identified and problem solved any potential barriers to 
completing project 
  
Physical or Active Learning Project 
29 Explained and demonstrated the project’s goal    
30 Discussed how the activity ties into group topic   
Balloon Breathing 
31 Explained and modeled breathing exercise    
32 Provided feedback to group and/or specific members 
about their practice 
  
33 Reminded members about goal of practicing daily or, at 
minimum, 3X before next session; record in log 
  
Volunteers 
34 Selected volunteer to explain session topics   
35 Selected volunteer to explain “Problem Solving” project   
36 Selected volunteer to demonstrate balloon breathing   
Rejoined Parent Group 
37 Had three volunteers share information with the parent 
group; provided assistance as needed 
  
38 Encouraged parents and children to work on their 
breathing exercise and projects 
  
Total:    
Total X items:   
Percent [Total Divided by (38 – number of X items) * 100]:   
*Can’t rate due to technical limitations (e.g., tape review--recording unclear, live observer-- had to leave room) 
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MF-PEP Therapist Adherence Checklist 
Child Session 6: Nonverbal Communication 
 
Specific Activities Score 
0=Not present 
1=Present 
X=Can’t rate* 
Comments 
Check-In 
1 Engaged a few members/families to briefly share their 
Week 5 project 
  
Identifying and Rating Feelings 
2 Asked members to identify and rate their feelings    
3 Shared feelings and intensity with group and identified 
reason for choice 
  
4 Engaged members to share their feelings and intensity 
with group along with reason for choice 
  
Session 6 Review/ Preview 
5 Gave each member a chance to share News of the 
Week 
  
6 Awarded points   
7 Reviewed members’ Week 5 project   
8 Addressed concerns related to difficulty understanding 
or completing the project 
  
9 For the following review, all shaded items should be 
briefly covered 
 NOTE: Tally only #9, not 9a-
e for final score 
9a Reviewed how thoughts, feelings, and behaviors are 
linked, each one affecting and being affected by the 
other two 
1        0       X  
9b Reviewed how we can transform hurtful/negative 
thoughts into more helpful/positive ones to change our 
feelings and behavior in a tough situation 
1        0       X  
9c Reviewed five steps of problem-solving: Stop; Think; 
Plan; Do; Check 
1        0       X  
9d Reviewed how to evaluate whether an action is positive 
or negative 
1        0       X  
9e Reviewed MF-PEP Motto 1        0       X  
10 For the following review, ≥ 33% of shaded items should 
be briefly covered 
 NOTE: Tally only #10, not 
10a-i for final score 
10a Reviewed family “Fix-It” list of goals to achieve by the 
end of group 
1        0       X  
10b Reviewed group rules 1        0       X  
10c Reviewed problems of ASD 1        0       X  
10d Reviewed breathing techniques 1        0       X  
10e Reviewed how problems of ASD can result in negative 
feelings about self and affect relationships with others 
1        0       X  
10f Reviewed treatment team members and how to be an 
active member of the team 
1        0       X  
10g Reviewed medications, common side effects, and how 
to manage side effects 
1        0       X  
10h Reviewed how triggers affect our mood 1        0       X  
10i Reviewed when to apply coping strategies from tool kits 1        0       X  
11 Previewed topics for Week 6   
Communication: Definition and Types 
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12 Began discussion by inquiring about getting in trouble 
for not listening or following directions  
  
13 Asked group to define communication   
14 Engaged members to generate and discuss definition - 
Key concepts: an exchange between two or more 
people; sharing ideas and feelings; listening to them; 
and acknowledging the information 
  
15 Processed with group why communication is important   
16 Engaged members to generate and discuss importance 
of communication – Key concepts: to let other know 
what you need, how you are feeling, and what you 
expect; to learn what others need, how they are feeling, 
and what they expect  
  
17 Explained verbal and nonverbal communication   
The Communication Cycle 
18 Explained communication cycle, highlighting sending 
and receiving a message from all participants involved 
  
19 Demonstrated communication cycle with members   
Communication Cards 
20 Explained and practiced interpreting and giving 
nonverbal communication focusing on facial 
expressions, voice tone, and body gestures  
  
Paying Attention to Feelings Project 
21 Reviewed the types of communication and the methods 
of each, as well as the communication cycle 
  
22 Explained instructions for completion of “Paying 
Attention to Feelings” project 
  
23 Identified and problem solved any potential barriers to 
completing project 
  
Physical or Active Learning Project 
24 Explained and demonstrated the goal of the project   
25 Discussed how the activity ties into group topic   
Balloon Breathing 
26 Explained and modeled breathing exercise    
27 Provided feedback to group and/or specific members 
about their breathing 
  
28 Reminded members about goal of practicing daily or, at 
minimum, 3X before next session; record in log 
  
Volunteers 
29 Selected volunteer to explain session topics   
30 Selected volunteer to explain the “Paying Attention to 
Feelings” project 
  
31 Selected volunteer to demonstrate bubble breathing   
Rejoined Parent Group 
32 Had three volunteers share their information with the 
parent group; provided assistance as needed 
  
33 Encouraged parents and children to work on their 
breathing exercise and projects 
  
Total:    
Total X items:   
Percent [Total Divided by (33 – number of X items) * 100]:   
*Can’t rate due to technical limitations (e.g., tape review--recording unclear, live observer-- had to leave room) 
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MF-PEP Therapist Adherence Checklist 
Child Session 7: Verbal Communication 
 
Specific Activities Score 
0=Not present 
1=Present 
X=Can’t rate* 
Comments 
Check-In  
1 Engaged a few members/families to briefly share their 
week 6 project 
  
Identifying and Rating Feelings 
2 Asked members to identify and rate their feelings    
3 Shared feelings and intensity with group and identified 
reason for choice 
  
4 Engaged members to share their feelings and intensity 
with group along with reason for choice 
  
Session 7 Review/ Preview 
5 Gave each member a chance to share News of the 
Week 
  
6 Awarded points   
7 Reviewed members’ Week 6 project   
8 Addressed concerns related to difficulty understanding 
or completing the project 
  
9 For the following review, all shaded items should be 
briefly covered to be present 
 NOTE: Tally only #9, not 9a-c 
for final score 
9a Reviewed five steps of problem-solving: Stop; Think; 
Plan; Do; Check 
1        0       X  
9b Reviewed how communication occurs in verbal and 
nonverbal ways and the communication cycle 
1        0       X  
9c Reviewed MF-PEP motto 1        0       X  
10 For the following review, ≥ 33% of shaded items should 
be briefly covered 
 NOTE: Tally only #10, not 
10a-l for final score 
10a Reviewed the family “Fix-It” list of goals to achieve by 
the end of group 
1        0       X  
10b Reviewed group rules 1        0       X  
10c Reviewed ASD problems 1        0       X  
10d Reviewed how to evaluate whether an action is positive 
or negative 
1        0       X  
10e Reviewed breathing techniques 1        0       X  
10f Reviewed how ASD problems can result in negative 
feelings about self and affect their relationships with 
others 
1        0       X  
10g Reviewed treatment team members and how to be an 
active member of the team 
1        0       X  
10h Reviewed medications, common side effects, and how 
to manage side effects 
1        0       X  
10i Reviewed how triggers affect our mood 1        0       X  
10j Reviewed when to apply coping strategies from tool 
kits 
1        0       X  
10k Reviewed how thoughts, feelings, and behaviors are 
linked, each one affecting and being affected by the 
other two 
1        0       X  
10l Reviewed how we can transform hurtful/negative 1        0       X  
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thoughts into more helpful/positive ones to change our 
feelings and behavior in a tough situation 
11 Previewed topics for Week 7   
Hurtful and Helpful Communication 
12 Began discussion by inquiring about examples when 
group members said things they did not mean or 
regretted saying afterwards  
  
13 Inquired how members felt after they engaged in hurtful 
communication 
  
14 Reviewed “I” statements   
15 Worked through hurtful communication examples in 
workbook and generated helpful alternatives 
  
Let’s Talk 
16 Introduced activity by explaining that everyone can 
work to improve outcomes of communication at home, 
school, and with friends 
  
17 Elicited and discussed group members’ examples of 
something they argue with parents about, problem-
solving with helpful communication alternatives 
  
18 Encouraged completion of “Let’s Talk!” worksheet   
19 Encouraged group members to share worksheet 
responses and provided feedback 
  
Let’s Talk Project 
20 Reviewed ways members can change hurtful 
messages to helpful messages, discussed outcomes of 
this process for the members and those around them 
  
21 Explained instructions to complete “Let’s Talk” project   
Physical or Active Learning Project 
22 Explained and demonstrated the goal of the project   
23 Discussed how the activity ties into group topic   
Favorite Breathing Exercise 
24 Explained and modeled breathing exercise    
25 Provided feedback to group and/or specific members 
about their breathing 
  
26 Reminded members about goal of practicing daily or, at 
minimum, 3X before next session; record in log 
  
Volunteers 
27 Selected volunteer to explain session topics   
28 Selected volunteer to explain the “Let’s Talk” project   
29 Selected volunteer to demonstrate favorite breathing 
exercise 
  
Rejoined Parent Group 
30 Had three volunteers share information with the parent 
group; provided assistance as needed 
  
31 Encouraged parents and children to work on their 
breathing exercise and projects 
  
 
Total:    
Total X items:   
Percent [Total Divided by (31 – number of X items) * 100]:   
*Can’t rate due to technical limitations (e.g., tape review--recording unclear, live observer-- had to leave room) 
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MF-PEP Therapist Adherence Checklist 
Child Session 8: Summary, Generalization, Revision, Cash in Points, Graduation 
 
Specific Activities Score 
0=Not present 
1=Present 
X=Can’t rate* 
Comments 
Check-In  
1 Engaged a few members/families to briefly share their 
Week 7 project 
  
Identifying and Rating Feelings 
2 Asked members to identify and rate their feelings    
3 Shared feelings and intensity with group and identified 
reason for choice 
  
4 Engaged members to share their feelings and intensity 
with group along with reason for choice 
  
Session 8 Review/ Preview 
5 Gave each member a chance to share News of the 
Week 
  
6 Awarded points   
7 Reviewed members’ Week 7 project   
8 Addressed concerns related to difficulty understanding 
or completing the project 
  
9 For the following review, all shaded items should be 
briefly covered  
 NOTE: Tally only #9, not 
9a-c for final score 
9a Reviewed how communication occurs in verbal and 
nonverbal ways and the communication cycle 
1        0        X  
9b Reviewed how to use “I statements” to transform hurtful 
communication to more helpful communication 
1        0        X  
9c Review MF-PEP motto 1        0        X  
10 For the following review a minimum of 33% of items 
should be briefly covered 
 NOTE: Tally only #10, not 
10a-m for final score 
10a Reviewed the family “Fix-It” list of goals to achieve by 
the end of group 
1        0        X  
10b Reviewed group rules 1        0        X  
10c Reviewed ASD problems 1        0        X  
10d Reviewed how to evaluate whether an action is helpful 
or hurtful 
1        0        X  
10e Reviewed breathing techniques 1        0        X  
10f Reviewed how ASD problems can result in negative 
feelings about self and affect relationships with others 
1        0        X  
10g Reviewed treatment team members and how to be an 
active member of the team 
1        0        X  
10h Reviewed medications, common side effects, and how 
to manage side effects 
1        0        X  
10i Reviewed how triggers affect our mood 1        0        X  
10j Reviewed when to apply coping strategies from tool kits 1        0        X  
10k Reviewed how thoughts, feelings, and behaviors are 
linked, each one affecting and being affected by the 
other two 
1        0        X  
10l Reviewed how we can transform hurtful/negative 
thoughts into more helpful/positive ones to change our 
feelings and behavior in a tough situation 
1        0        X  
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10m Reviewed five steps of problem-solving: Stop; Think; 
Plan; Do; Check 
1        0        X  
MF-PEP Review Game 
11 Explained directions for MF-PEP review game    
12 Facilitated game with 4 categories of questions: 1) 
Problems/Medications; 2) Thinking-Feeling-Doing; 3) 
Anger Management/Coping; and 4) Problem 
Solving/Communication 
  
13 After game, asked members for recommendations for 
future groups 
  
Selecting Prizes 
14 Totaled group members’ points   
15 Facilitated selection of prizes   
Rejoined Parent Group 
16 Presented graduation certificates    
17 Provided congratulation speech for each child/family   
18 Addressed concerns and questions   
 
Total:    
Total X items:   
Percent [Total Divided by (18 – number of X items) * 100]:   
*Can’t rate due to technical limitations (e.g., tape review--recording unclear, live observer-- had to leave room) 
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Table 1 
Internal Consistency of the Therapist Adherence Checklist (Child-Version) 
Session Na Cronbach’s Alpha 
1 45 .67 
2 41 .61 
3 41 .78 
4 45 .63 
5 38 .67 
6 28 .56 
7 31 .56 
8 19 .48 
aN refers to number of items on each measure 
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Table 2 
Intraclass Correlation Coefficients for the Therapist Adherence Checklist (Child-Version) 
 
 
 
 
 
 
 
 
 
 
 
 
Group/Session ICC (3,1) 
Fall Session 1 .56 
Fall Session 2 .79 
Fall Session 3 .69 
Fall Session 4 .62 
Fall Session 5 .44 
Fall Session 6 .36 
Fall Session 7 --- 
Fall Session 8 .32 
Average Fall  .54 
  
Winter Session 1 .66 
Winter Session 2 .22 
Winter Session 3 .63 
Winter Session 4 __ 
Winter Session 5 .31 
Winter Session 6 .46 
Winter Session 7 .39 
Winter Session 8 --- 
Average Winter .44 
